GeoVax Labs, Inc. (GOVX): Nasdaq/NYSE listing notice — GeoVax regains Nasdaq compliance after reverse stock split, delisting cancelled

GeoVax Labs, Inc.

Received Nasdaq delisting notice Dec 6, 2023 for bid price below $1.00.
Effected 1-for-? reverse stock split on Jan 31, 2024; shares then traded above $1.00 for 10 consecutive days.
On Feb 16, 2024, Nasdaq confirmed compliance regained; hearing cancelled and listing maintained.
GeoVax common (GOVX) and warrants (GOVXW) continue trading on Nasdaq Capital Market.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GeoVax Labs, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 16, 2024, the Company received a letter from Nasdaq stating that Nasdaq has determined the Company to have regained compliance with The Nasdaq Capital Market listing requirements and that, consequently, the scheduled Hearing has been cancelled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market.

View on SEC.gov

Browse all listing & compliance notices →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-004557

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.